Stephanie E B McArdle
Overview
Explore the profile of Stephanie E B McArdle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pearson J, Puig-Saenz C, Thomas J, Hardowar L, Ahmad M, Wainwright L, et al.
Cancer Immunol Immunother
. 2024 Jul;
73(9):178.
PMID: 38954031
Intracranial tumors present a significant therapeutic challenge due to their physiological location. Immunotherapy presents an attractive method for targeting these intracranial tumors due to relatively low toxicity and tumor specificity....
2.
McArdle S, Nagarajan D, Barish M
Front Immunol
. 2024 May;
15:1407930.
PMID: 38715607
No abstract available.
3.
Puig-Saenz C, Pearson J, Thomas J, McArdle S
Biomedicines
. 2023 Aug;
11(8).
PMID: 37626597
Immunotherapy represents an attractive avenue for cancer therapy due to its tumour specificity and relatively low frequency of adverse effects compared to other treatment modalities. Despite many advances being made...
4.
Habra K, Pearson J, McArdle S
FEBS Open Bio
. 2023 Jun;
13(7):1266-1277.
PMID: 37317692
While useful for fundamental in vitro studies, monolayer cell cultures are not physiologically relevant. Spheroids, a complex three-dimensional (3D) structure, more closely resemble in vivo tumor growth. Spheroids allow the...
5.
Habra K, Morris R, McArdle S, Cave G
Nanoscale Adv
. 2022 Sep;
4(10):2242-2249.
PMID: 36133698
Nanometer scale rods of superparamagnetic iron oxide have been encapsulated, along with the anti-cancer therapeutic carnosine, inside porous poly(lactic--glycolic acid) microbeads with a uniform morphology, synthesised using microfluidic arrays. The...
6.
McArdle S, Pawelec G, Pockley A, Johansen P
Front Immunol
. 2021 Nov;
12:771319.
PMID: 34721440
No abstract available.
7.
Habra K, McArdle S, Morris R, Cave G
Nanomaterials (Basel)
. 2021 Sep;
11(9).
PMID: 34578472
The complete removal of glioblastoma brain tumours is impossible to achieve by surgery alone due to the complex finger-like tentacle structure of the tumour cells and their migration away from...
8.
Cuzzubbo S, Mangsbo S, Nagarajan D, Habra K, Pockley A, McArdle S
Front Immunol
. 2021 Mar;
11:615240.
PMID: 33679703
Although the discovery and characterization of multiple tumor antigens have sparked the development of many antigen/derived cancer vaccines, many are poorly immunogenic and thus, lack clinical efficacy. Adjuvants are therefore...
9.
Pearson J, Cuzzubbo S, McArthur S, Durrant L, Adhikaree J, Tinsley C, et al.
Front Immunol
. 2020 Nov;
11:582106.
PMID: 33178210
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis, with only around 5% of patients surviving for a period of 5 years...
10.
Alves R, McArdle S, Vadakekolathu J, Goncalves A, Freitas-Tavares P, Pereira A, et al.
J Transl Med
. 2020 Jan;
18(1):2.
PMID: 31900171
Background: Tumor cells have evolved complex strategies to escape immune surveillance, a process which involves NK cells and T lymphocytes, and various immunological factors. Indeed, tumor cells recruit immunosuppressive cells...